Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?
Porcellati, F.; Di Mauro, S.; Mazzieri, A.; Scamporrino, A.; Filippello, A.; De Fano, M.; Fanelli, C.G.; Purrello, F.; Malaguarnera, R.; Piro, S. Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin? Biomolecules 2021, 11, 1281. https://doi.org/10.3390/biom11091281
Porcellati F, Di Mauro S, Mazzieri A, Scamporrino A, Filippello A, De Fano M, Fanelli CG, Purrello F, Malaguarnera R, Piro S. Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin? Biomolecules. 2021; 11(9):1281. https://doi.org/10.3390/biom11091281
Chicago/Turabian StylePorcellati, Francesca, Stefania Di Mauro, Alessio Mazzieri, Alessandra Scamporrino, Agnese Filippello, Michelantonio De Fano, Carmine G. Fanelli, Francesco Purrello, Roberta Malaguarnera, and Salvatore Piro. 2021. "Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?" Biomolecules 11, no. 9: 1281. https://doi.org/10.3390/biom11091281